BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9678429)

  • 21. Oxidation of extracellular matrix modulates susceptibility to degradation by the mesangial matrix metalloproteinase-2.
    Mattana J; Margiloff L; Chaplia L
    Free Radic Biol Med; 1999 Aug; 27(3-4):315-21. PubMed ID: 10468204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular factors altered in glucose-treated mesangial cells and diabetic glomeruli. Changes in vascular factors impair endothelial cell growth and matrix.
    Singh AK; Gudehithlu KP; Pegoraro AA; Singh GK; Basheerudin K; Robey RB; Arruda JA; Dunea G
    Lab Invest; 2004 May; 84(5):597-606. PubMed ID: 15048134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesangial cells from transgenic mice with progressive glomerulosclerosis exhibit stable, phenotypic changes including undetectable MMP-9 and increased type IV collagen.
    Jacot TA; Striker GE; Stetler-Stevenson M; Striker LJ
    Lab Invest; 1996 Dec; 75(6):791-9. PubMed ID: 8973474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gelatinase is the main matrix metalloproteinase involved in granuloma-induced cartilage degradation.
    Trancart MM; Chalmeigne N; Girardot C; Zarpanelian C; Prigent D
    Int J Tissue React; 1992; 14(6):287-94. PubMed ID: 1339118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of megsin, a serine protease inhibitor, in diabetic mesangial matrix accumulation.
    Ohtomo S; Nangaku M; Izuhara Y; Yamada N; Dan T; Mori T; Ito S; van Ypersele de Strihou C; Miyata T
    Kidney Int; 2008 Sep; 74(6):768-74. PubMed ID: 18580857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation and inhibition of endogenous matrix metalloproteinases in articular cartilage: effects on composition and biophysical properties.
    Bonassar LJ; Stinn JL; Paguio CG; Frank EH; Moore VL; Lark MW; Sandy JD; Hollander AP; Poole AR; Grodzinsky AJ
    Arch Biochem Biophys; 1996 Sep; 333(2):359-67. PubMed ID: 8809074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of metalloproteinases by glomerular mesangial cells stimulated by proteins of the extracellular matrix.
    Martin J; Eynstone L; Davies M; Steadman R
    J Am Soc Nephrol; 2001 Jan; 12(1):88-96. PubMed ID: 11134254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasoactive agents modulate matrix metalloproteinase-2 activity by mesangial cells.
    Singhal PC; Sagar S; Garg P; Bansal V
    Am J Med Sci; 1995 Dec; 310(6):235-41. PubMed ID: 7503103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluorescence quenching studies of matrix metalloproteinases (MMPs): evidence for structural rearrangement of the proMMP-2/TIMP-2 complex upon mercurial activation.
    Stack MS; Itoh Y; Young TN; Nagase H
    Arch Biochem Biophys; 1996 Sep; 333(1):163-9. PubMed ID: 8806767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetes mellitus increases endothelin-1 gene transcription in rat kidney.
    Hargrove GM; Dufresne J; Whiteside C; Muruve DA; Wong NC
    Kidney Int; 2000 Oct; 58(4):1534-45. PubMed ID: 11012888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purification of aminophenyl mercuryacetate-activated human matrix metalloproteinase 1 and removal of the organomercurial in a single-step chromatography.
    Huse K; Wippich P; Gutknecht D; Aust G; Scholz GH
    Bioseparation; 1999; 7(6):281-6. PubMed ID: 10643638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential MMP-2 activity of ligament cells under mechanical stretch injury: an in vitro study on human ACL and MCL fibroblasts.
    Zhou D; Lee HS; Villarreal F; Teng A; Lu E; Reynolds S; Qin C; Smith J; Sung KL
    J Orthop Res; 2005 Jul; 23(4):949-57. PubMed ID: 16023011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High ambient glucose enhances sensitivity to TGF-beta1 via extracellular signal--regulated kinase and protein kinase Cdelta activities in human mesangial cells.
    Hayashida T; Schnaper HW
    J Am Soc Nephrol; 2004 Aug; 15(8):2032-41. PubMed ID: 15284289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Regulation of matrix-degrading enzymes in gynecologic cancer tissues and cells].
    Kikkawa F
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):618-22. PubMed ID: 8808829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic exposure of human mesangial cells to high glucose environments activates the p38 MAPK pathway.
    Wilmer WA; Dixon CL; Hebert C
    Kidney Int; 2001 Sep; 60(3):858-71. PubMed ID: 11532081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High glucose induces type 1 hexokinase gene expression in isolated glomeruli of diabetic rats and in mesangial cells.
    Henningsen C; Zahner G; Thaiss F
    Nephron Physiol; 2003; 93(3):p67-75. PubMed ID: 12660493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin II-induced modulation of rat mesangial cell phenotype.
    Zhang X; O'Malley Y; Robbins ME
    Radiat Res; 1999 Jun; 151(6):725-35. PubMed ID: 10360793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucose-induced oxidative stress in mesangial cells.
    Catherwood MA; Powell LA; Anderson P; McMaster D; Sharpe PC; Trimble ER
    Kidney Int; 2002 Feb; 61(2):599-608. PubMed ID: 11849402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secretion of different types of gelatinases from cultured human keratinocytes.
    Kobayashi T; Hattori S; Nagai Y; Sakuraoka K; Nishikawa T
    J Dermatol; 1997 Apr; 24(4):213-6. PubMed ID: 9164060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of metalloproteinase-2 by membrane type metalloproteinase expressed on human mesangial cell membrane.
    Tomosugi N; Sato H; Seiki M; Yamaya H; Yuri T; Nakamura M; Nakazawa T; Asaka M; Ishikawa I
    Contrib Nephrol; 1996; 118():135-40. PubMed ID: 8744050
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.